Discordance Between Cerebrospinal Fluid Biomarkers and Amyloid Positron Emission Tomography in Alzheimer's Sheds Light on Clinical Trial Exclusion Criteria Article

publication date

  • February 22, 2021

webpage

published in

keywords

  • alzheimer's
  • biomarkers
  • clinical trials
  • dementia
  • discordance

volume

  • 13

issue

  • 2